Results 271 to 280 of about 226,308 (303)

Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients

New England Journal of Medicine, 2023
Steven Nissen, Kausik Ray, John J P Kastelein   +2 more
exaly  

Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial

Lancet, The, 2022
exaly  

Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials

Lancet, The, 2018
Peter Willeit, Paul M Ridker, Andrew M Tonkin   +2 more
exaly  

Statins

New Scientist, 2015
James M. McKenney, Eli M. Roth
openaire   +2 more sources

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial

Lancet, The, 2012
Paul M Ridker, Peter Libby, Robert J Glynn   +2 more
exaly  

Interpretation of the evidence for the efficacy and safety of statin therapy

Lancet, The, 2016
Rory Collins, Jonathan R Emberson, Jane Armitage, Frcp   +2 more
exaly  

Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

Lancet, The, 2019
Jane Armitage, Frcp, Colin Baigent, Christopher P Cannon   +2 more
exaly  

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

Lancet, The, 2012
Borislava Mihaylova
exaly  

Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials

Lancet, The, 2015
Mark J Caulfield, Christopher P Cannon, Neil R Poulter   +2 more
exaly  

Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials

Lancet, The, 2023
exaly